| 1. |
- Emberson, Lisa D., et al.
(författare)
-
Ozone effects on crops and consideration in crop models
- 2018
-
Ingår i: European Journal of Agronomy. - : Elsevier BV. - 1161-0301. ; 100:Special Issue: SI, s. 19-34
-
Tidskriftsartikel (refereegranskat)abstract
- © 2018 The Authors We review current knowledge of the processes by which ozone will cause injury and damage to crop plants. We do this both through an understanding of the limitations to ozone uptake (i.e. ozone being transferred from some height in the atmosphere to the leaf boundary layer and subsequent uptake via the stomata) as well as through the internal plant processes that will result in the absorbed ozone dose causing damage and/or injury. We consider these processes across a range of scales by which ozone impacts plants, from cellular metabolism influencing leaf level physiology up to whole canopy and root system processes and feedbacks. We explore how these impacts affect leaf level photosynthesis and senescence (and associated carbon assimilation) as well as whole canopy resource acquisition (e.g. water and nutrients) and ultimately crop growth and yield. We consider these processes from the viewpoint of developing crop growth models capable of incorporating key ozone impact processes within modelling structures that assess crop growth under a variety of different abiotic stresses. These models would provide a dynamic assessment of the impact of ozone within the context of other key variables considered important in determining crop growth and yield. We consider the ability to achieve such modelling through an assessment of the different types of crop model currently available (e.g. empirical, radiation use efficiency, and photosynthesis based crop growth models). Finally, we show how international activities such as the AgMIP (Agricultural Modelling and Improvement Intercomparison Project) could see crop growth modellers collaborate to assess the capabilities of different crop models to simulate the effects of ozone and other stresses. The development of robust crop growth models capable of including ozone effects would substantially improve future national, regional and global risk assessments that aim to assess the role that ozone might play under future climatic conditions in limiting food supply.
|
|
| 2. |
- Feng, Zhaozhong, et al.
(författare)
-
A unifying explanation for variation in ozone sensitivity among woody plants
- 2018
-
Ingår i: Global Change Biology. - : Wiley. - 1354-1013 .- 1365-2486. ; 24:1, s. 78-84
-
Tidskriftsartikel (refereegranskat)abstract
- Tropospheric ozone is considered the most detrimental air pollutant for vegetation at the global scale, with negative consequences for both provisioning and climate regulating ecosystem services. In spite of recent developments in ozone exposure metrics, from a concentration-based to a more physiologically relevant stomatal flux-based index, large-scale ozone risk assessment is still complicated by a large and unexplained variation in ozone sensitivity among tree species. Here, we explored whether the variation in ozone sensitivity among woody species can be linked to interspecific variation in leaf morphology. We found that ozone tolerance at the leaf level was closely linked to leaf dry mass per unit leaf area (LMA) and that whole-tree biomass reductions were more strongly related to stomatal flux per unit leaf mass (r 2 =0.56) than to stomatal flux per unit leaf area (r 2 =0.42). Furthermore, the interspecific variation in slopes of ozone flux–response relationships was considerably lower when expressed on a leaf mass basis (coefficient of variation, CV=36%) than when expressed on a leaf area basis (CV=66%), and relationships for broadleaf and needle-leaf species converged when using the mass-based index. These results show that much of the variation in ozone sensitivity among woody plants can be explained by interspecific variation in LMA and that large-scale ozone impact assessment could be greatly improved by considering this well-known and easily measured leaf trait.
|
|
| 3. |
- Herrington, William, et al.
(författare)
-
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens : a meta-analysis of individual participant data from 28 randomised trials
- 2016
-
Ingår i: The Lancet Diabetes and Endocrinology. - 2213-8587 .- 2213-8595. ; 4:10, s. 829-839
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND: Statin therapy is effective for the prevention of coronary heart disease and stroke in patients with mild-to-moderate chronic kidney disease, but its effects in individuals with more advanced disease, particularly those undergoing dialysis, are uncertain.METHODS: We did a meta-analysis of individual participant data from 28 trials (n=183 419), examining effects of statin-based therapy on major vascular events (major coronary event [non-fatal myocardial infarction or coronary death], stroke, or coronary revascularisation) and cause-specific mortality. Participants were subdivided into categories of estimated glomerular filtration rate (eGFR) at baseline. Treatment effects were estimated with rate ratio (RR) per mmol/L reduction in LDL cholesterol.FINDINGS: Overall, statin-based therapy reduced the risk of a first major vascular event by 21% (RR 0·79, 95% CI 0·77-0·81; p<0·0001) per mmol/L reduction in LDL cholesterol. Smaller relative effects on major vascular events were observed as eGFR declined (p=0·008 for trend; RR 0·78, 99% CI 0·75-0·82 for eGFR ≥60 mL/min per 1·73 m(2); 0·76, 0·70-0·81 for eGFR 45 to <60 mL/min per 1·73 m(2); 0·85, 0·75-0·96 for eGFR 30 to <45 mL/min per 1·73 m(2); 0·85, 0·71-1·02 for eGFR <30 mL/min per 1·73 m(2) and not on dialysis; and 0·94, 0·79-1·11 for patients on dialysis). Analogous trends by baseline renal function were seen for major coronary events (p=0·01 for trend) and vascular mortality (p=0·03 for trend), but there was no significant trend for coronary revascularisation (p=0·90). Reducing LDL cholesterol with statin-based therapy had no effect on non-vascular mortality, irrespective of eGFR.INTERPRETATION: Even after allowing for the smaller reductions in LDL cholesterol achieved by patients with more advanced chronic kidney disease, and for differences in outcome definitions between dialysis trials, the relative reductions in major vascular events observed with statin-based treatment became smaller as eGFR declined, with little evidence of benefit in patients on dialysis. In patients with chronic kidney disease, statin-based regimens should be chosen to maximise the absolute reduction in LDL cholesterol to achieve the largest treatment benefits.FUNDING: UK Medical Research Council, British Heart Foundation, Cancer Research UK, European Community Biomed Programme, Australian National Health and Medical Research Council, Australian National Heart Foundation.
|
|
| 4. |
- Herrington, William, et al.
(författare)
-
The effect of lowering LDL cholesterol on vascular access patency : post hoc analysis of the Study of Heart and Renal Protection
- 2014
-
Ingår i: Clinical journal of the American Society of Nephrology : CJASN. - 1555-905X. ; 9:5, s. 914-919
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND AND OBJECTIVES:Reducing LDL cholesterol (LDL-C) with statin-based therapy reduces the risk of major atherosclerotic events among patients with CKD, including dialysis patients, but the effect of lowering LDL-C on vascular access patency is unclear.DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS:The Study of Heart and Renal Protection (SHARP) randomized patients with CKD to 20 mg simvastatin plus 10 mg ezetimibe daily versus matching placebo. This study aimed to explore the effects of treatment on vascular access occlusive events, defined as any access revision procedure, access thrombosis, removal of an old dialysis access, or formation of new permanent dialysis access.RESULTS:Among 2353 SHARP participants who had functioning vascular access at randomization, allocation to simvastatin plus ezetimibe resulted in a 13% proportional reduction in vascular access occlusive events (355 [29.7%] for simvastatin/ezetimibe versus 388 [33.5%] for placebo; risk ratio [RR], 0.87; 95% confidence interval [95% CI], 0.75 to 1.00; P=0.05). There was no evidence that the effects of treatment differed for any of the separate components of this outcome. To test the hypothesis raised by SHARP, comparable analyses were performed using the AURORA (A Study to Evaluate the Use of Rosuvastatin in Subjects on Regular Hemodialysis: An Assessment of Survival and Cardiovascular Events) trial cohort. AURORA did not provide independent confirmation (vascular access occlusive events: 352 [28.9%] for rosuvastatin versus 337 [27.6%] for placebo; RR, 1.06, 95% CI, 0.91 to 1.23; P=0.44). After combining the two trials, the overall effect of reducing LDL-C with a statin-based regimen on vascular access occlusive events was not statistically significant (707 [29.3%] with any LDL-C-lowering therapy versus 725 [30.5%] with placebo; RR, 0.95, 95% CI, 0.85 to 1.05; P=0.29).CONCLUSIONS:Exploratory analyses from SHARP suggest that lowering LDL-C with statin-based therapy may improve vascular access patency, but there was no evidence of benefit in AURORA. Taken together, the available evidence suggests that any benefits of lowering LDL-C on vascular access patency are likely to be modest.
|
|
| 5. |
- Mills, Gina, 1959, et al.
(författare)
-
Closing the global ozone yield gap: Quantification and cobenefits for multistress tolerance
- 2018
-
Ingår i: Global Change Biology. - : Wiley. - 1354-1013 .- 1365-2486. ; 24:10, s. 4869-4893
-
Tidskriftsartikel (refereegranskat)abstract
- Increasing both crop productivity and the tolerance of crops to abiotic and biotic stresses is a major challenge for global food security in our rapidly changing climate. For the first time, we show how the spatial variation and severity of tropospheric ozone effects on yield compare with effects of other stresses on a global scale, and discuss mitigating actions against the negative effects of ozone. We show that the sensitivity to ozone declines in the order soybean>wheat>maize>rice, with genotypic variation in response being most pronounced for soybean and rice. Based on stomatal uptake, we estimate that ozone (mean of 2010–2012) reduces global yield annually by 12.4%, 7.1%, 4.4% and 6.1% for soybean, wheat, rice and maize, respectively (the “ozone yield gaps”), adding up to 227Tg of lost yield. Our modelling shows that the highest ozone-induced production losses for soybean are in North and South America whilst for wheat they are in India and China, for rice in parts of India, Bangladesh, China and Indonesia, and for maize in China and the United States. Crucially, we also show that the same areas are often also at risk of high losses from pests and diseases, heat stress and to a lesser extent aridity and nutrient stress. In a solution-focussed analysis of these results, we provide a crop ideotype with tolerance of multiple stresses (including ozone) and describe how ozone effects could be included in crop breeding programmes. We also discuss altered crop management approaches that could be applied to reduce ozone impacts in the shorter term. Given the severity of ozone effects on staple food crops in areas of the world that are also challenged by other stresses, we recommend increased attention to the benefits that could be gained from addressing the ozone yield gap.
|
|
| 6. |
|
|
